On April 20, 2018, HemoSonic LLC (“Petitioner”) filed a Petition to the USPTO’s Patent Trial and Appeal Board (“Board”) for an inter partes review of claims 1-40 of U.S. Patent No. 9,915,671 (“the ‘671 Patent”). The ‘671 Patent is owned by C.A. Casyso GMBH and is drawn to a cartridge for use with a measuring system for assessing the blood coagulation process. In the Petition, Petitioner alleges that claims 1-40 of the patent are obvious under 35 U.S.C. § 103 over various patent and non-patent literature documents. The inter partes review remains pending at the Board and is captioned IPR2018-00950.
By: Jacqueline A. DiRamio